Intellia Therapeutics Inc buy Cantor Fitzgerald
Start price
04.06.24
/
50%
€21.64
Target price
04.06.25
€59.71
Performance (%)
-24.77%
Price
07.10.24
€16.28
Summary
This prediction is currently active. The prediction for Intellia Therapeutics Inc disappoints with a performance of -24.77%. This prediction currently runs until 04.06.25. The prediction end date can be changed by Cantor_Fitzgerald at any time. Cantor_Fitzgerald has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Intellia Therapeutics Inc | -11.833% | -11.833% |
iShares Core DAX® | -1.958% | 4.037% |
iShares Nasdaq 100 | 0.272% | 8.670% |
iShares Nikkei 225® | 0.377% | 7.232% |
iShares S&P 500 | 0.370% | 6.511% |
Comments by Cantor_Fitzgerald for this prediction
In the thread Intellia Therapeutics Inc diskutieren
Intellia Therapeutics, Inc. (NASDAQ: NTLA) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $65.00 price target on the stock.
Ratings data for NTLA provided by MarketBeat
Stopped prediction by Cantor_Fitzgerald for Intellia Therapeutics Inc
Intellia Therapeutics Inc
Start price
Target price
Perf. (%)
€23.43
24.06.24
24.06.24
€60.53
24.06.25
24.06.25
-30.52%
07.10.24
07.10.24
Intellia Therapeutics Inc
Start price
Target price
Perf. (%)
€22.97
18.06.24
18.06.24
€60.53
18.06.25
18.06.25
-29.12%
07.10.24
07.10.24
Intellia Therapeutics Inc
Start price
Target price
Perf. (%)
€34.13
13.09.23
13.09.23
€60.55
13.09.24
13.09.24
-41.20%
14.09.24
14.09.24
Intellia Therapeutics Inc
Start price
Target price
Perf. (%)
€35.09
29.08.23
29.08.23
€59.70
29.08.24
29.08.24
-42.43%
30.08.24
30.08.24
Intellia Therapeutics Inc
Start price
Target price
Perf. (%)
€37.03
10.08.23
10.08.23
€58.92
10.08.24
10.08.24
-46.44%
11.08.24
11.08.24